Review
Published on 02 Jun 2023
Targeting CD137 (4-1BB) towards improved safety and efficacy for cancer immunotherapy
in Molecular Innate Immunity
Frontiers in Immunology
doi 10.3389/fimmu.2023.1208788
- 12,866 views
- 18 citations
Review
Published on 02 Jun 2023
in Molecular Innate Immunity
Review
Published on 15 Nov 2018
in T Cell Biology
Original Research
Published on 20 Jun 2025
in Cancer Immunity and Immunotherapy
Original Research
Published on 10 Oct 2017
in Cancer Immunity and Immunotherapy
Methods
Published on 15 Feb 2024
in Cancer Immunity and Immunotherapy
Original Research
Published on 23 Nov 2021
in T Cell Biology